missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30031637

LZIC Antibody (OTI3A7), PerCP, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-72559PCP

Product Code. 30031637

  • € 740.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

LZIC Monoclonal antibody specifically detects LZIC in Human, Mouse, Rat, Canine, Monkey samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

LZIC
Monoclonal
PerCP
PBS
Mouse
Immunogen affinity purified
RUO
Primary
Human, Mouse, Rat, Canine, Monkey
Purified
Western Blot, Immunohistochemistry, Immunocytochemistry
OTI3A7
Western Blot, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence
leucine zipper and CTNNBIP1 domain containing, Leucine zipper and CTNNBIP1 domain-containing protein, Leucine zipper and ICAT homologous domain-containing protein, leucine zipper domain and ICAT homologous domain containing, MGC15436, protein LZIC
Human recombinant protein fragment corresponding to amino acids 1-190 of human LZIC (NP_115744) produced in E.coli.
0.1 mL
Neuroscience
84328
Store at 4C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.